Bajao, Veronica H.

HRN: 29-72-81  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2025
CEFTAZIDIME 1GM (VIAL)
02/19/2025
02/26/2025
IV
1g
Every 8 Hours
DM Foot, Right
Waiting Final Action 
02/19/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/19/2025
02/26/2025
IV
600mg
Every 8 Hours
DM Foot, Right
Waiting Final Action 
03/04/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/04/2025
03/11/2025
IV
600
Q8
DM Type 2
Waiting Final Action 
03/04/2025
CEFUROXIME 750MG (VIAL)
03/04/2025
03/11/2025
IV
750
Q8
DM Type 2
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: